News | Clinical Decision Support | July 10, 2018

Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging

Agreement aims to develop and market software solutions to aid physicians' in their treatment recommendations and follow-up care for liver cancer

Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging

July 10, 2018 — Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an artificial intelligence (AI) software solution to support liver cancer diagnostics. The AI software will focus on utilizing computed tomography (CT) and magnetic resonance imaging (MRI), and care.

Through this collaboration, Guerbet and IBM Watson Health plan to co-develop clinical decision support solutions. The first, called Watson Imaging Care Advisor for Liver [1], is planned to be a diagnostic support tool that will use AI to automate the detection, staging, tracking, monitoring, and therapy prediction and response of primary and secondary liver cancer for clinicians. The IBM Research team will also work on development of the solutions leveraging prior research innovations.

Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50 percent of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.

Care Advisor for Liver will be designed to be compatible with the most common picture archiving and communication systems (PACS), making it easy to be integrated directly into the workflows of healthcare professionals.

Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients. These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.

For more information: www.guerbet.com, www.ibm.com/watson/health

References

[1] Care Advisor is not yet a formally approved product name.

[2] http://www.who.int/news-room/fact-sheets/detail/cancer

[3] http://pressroom.cancer.org/LiverCancer2017

[4] https://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/liver-cancer-statistics

[5] https://www.sciencedirect.com/science/article/pii/S2211568414000941

Related Content

DR 800 multi-purpose digital imaging system with Dynamic Musica
News | Digital Radiography (DR) | July 20, 2018
Agfa displayed the new DR 800 multi-purpose digital imaging system with Dynamic ...
Fujifilm to Host Pediatric Imaging Best Practices Symposium at AHRA 2018
News | Pediatric Imaging | July 18, 2018
Fujifilm Medical Systems U.S.A. Inc. announced that it will offer educational opportunities and exhibit its latest...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Study Points to Need for Performance Standards for EHR Usability and Safety
News | Electronic Medical Records (EMR) | July 18, 2018
A novel new study provides compelling evidence that the design, development and implementation of electronic health...
Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
2019 Proposed Physician Fee Schedule Appropriate Use Criteria Summary
Feature | Clinical Decision Support | July 13, 2018 | Nathan Baugh
On July 12, the Centers for Medicare and Medicaid Services (CMS) released the proposed rule for the 2019 Physician Fe
Siemens Healthineers Launches Acuson Sequoia Ultrasound
Technology | Ultrasound Imaging | July 12, 2018
July 12, 2018 — Siemens Healthineers recently announced the launch of its new ultrasound system, the Acuson Sequoia.
Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality
News | Mammography | July 11, 2018
Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is...
Overlay Init